INS and type 2 diabetes mellitus: In total, 1104 T2DM participants with a mean (SD) age of 57.65 (10.21) years at the 10 study centers were enrolled in the present analysis, among whom 471 (42.7%) participants received twice‐daily premixed insulin and 633 (57.3%) received once‐daily basal insulin.